Aprio Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.07M Buy
12,570
+672
+6% +$60.8K 0.05% 238
2026
Q2
$1.09M Buy
11,898
+1,148
+11% +$100K 0.05% 221
2026
Q1
$916K Buy
10,750
+5,874
+120% +$524K 0.05% 227
2025
Q4
$848K Buy
4,876
+2,327
+91% +$182K 0.05% 227
2025
Q3
$204K Sell
2,549
-1,731
-40% -$148K 0.02% 420
2025
Q2
$389K Sell
4,280
-1,504
-26% -$137K 0.04% 235
2025
Q1
$542K Buy
5,784
+2,713
+88% +$243K 0.07% 170
2024
Q4
$279K Buy
3,071
+37
+1% +$3.53K 0.04% 230
2024
Q3
$315K Buy
3,034
+481
+19% +$49K 0.05% 191
2024
Q2
$248K Buy
+2,553
New +$236K 0.05% 202

Other funds holding CL

Aprio Wealth Management's CL Position: Q3 2026 in Review

Aprio Wealth Management increased its Colgate-Palmolive (CL) stake by 5.6% in Q3 2026, buying an estimated $60.8K and bringing the position to 12,570 shares worth $1.07M. The position accounts for 0.05% of the portfolio, ranked #238.

Aprio Wealth Management first reported a position in CL in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.09M in Q2 2026. 808 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Aprio Wealth Management held 12,570 shares of Colgate-Palmolive worth $1.07M as of Q3 2026.
  • Aprio Wealth Management bought 672 Colgate-Palmolive shares in Q3 2026, an estimated $60.8K.
  • Colgate-Palmolive made up 0.05% of Aprio Wealth Management's portfolio in Q3 2026, its #238 holding.
  • Aprio Wealth Management first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 10 quarters since.
  • Aprio Wealth Management's Colgate-Palmolive position peaked at $1.09M in Q2 2026.
  • 808 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Aprio Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.